Related Experiment Video
Updated: Aug 26, 2026

Tuina Manipulation to Reduce Inflammation and Cartilage Loss in Knee Osteoarthritis Rats
Published on: June 30, 2023
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
1Rheumatology Research and Advanced Therapeutics, University Medical Center Nijmegen, The Netherlands. w.vandenberg@reuma.azn.nl
Abstract:
TNF and IL-1 are master cytokines in chronic destructive arthritis. Therapeutic approaches have so far focused mainly on TNF which is a major inflammatory mediator in RA and a potent inducer of IL-1. Anti-TNF treatment shows great efficacy in RA patients. However, it is not effective in all patients, nor does it fully control the arthritic process in affected joints of good responders. Although TNF is an early mediator and often crucial in onset of experimental arthritis, studies in rodent models revealed that TNF independent IL-1 production does occur in many arthritic situations. These include direct, innate macrophage activation by phlogistic stimuli, but also immune driven conditions of immune complex and T cell mediated arthritis. If elements of the models apply to the arthritic process in RA patients, it is necessary to block IL-1 in addition to TNF.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents